Skip to content

the use of topical tranexamic acid in total hip arthroplasty

The comparison of intravenous tranexamic acid and topical tranexamic acid efficacy on postoperative bleeding after total hip arthroplasty surgery.

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
IRCT
Registry ID
IRCT201509056280N8
Enrollment
100
Registered
2015-10-24
Start date
2015-10-23
Completion date
Unknown
Last updated
2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Patients candidate for total hip arthroplasty. Multiple injuries of hip and thigh

Interventions

Intervention 1: . In intravenous tranexamic acid group (15mg/kg), transamine will administer by anesthesiologist and based on body weight in a time of 10 minute. Before skin incision and surgery, all
Treatment - Drugs
. In intravenous tranexamic acid group (15mg/kg), transamine will administer by anesthesiologist and based on body weight in a time of 10 minute. Before skin incision and surgery, all the patients rec
In tranexamic topical group,patients will recieve 3gr of tranexamic acid(6 vials) that diluted with normal saline intraoperatively by orthoped.After rimming of acetabulom 30 ml of above solution inse

Sponsors

Vice Chancellaor foe Research of Guilan University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
20 Years to 50 Years

Inclusion criteria

Inclusion criteria: Inclusion criteria: patients who undergoing total hip arthroplasty surgery; 50-20 years old; ASA (American Society of Anesthesia) I-II; having HB= 10gr dl before surgery ; not receiving transfusion before surgery. The exclusion criteria: Emergency surgery; Hb<10mg/dl; The evidence for any condition of IHD or treatment; The evidence for hemorrhagic CVA ; SAH OR STROK; The evidence for TBI; Use of anticoagulant drug; any history of renal ; liver and anemia before operation; History of OCP consumption.

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
Intraoperative and postoperative hemorrhage. Timepoint: after operation and 24 hours after that. Method of measurement: based on blod on suction and gauze counting and gilcher formula.

Secondary

MeasureTime frame
Packed cell. Timepoint: intraoperative and 24 hours after surgery. Method of measurement: number of packed cell.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactMohammad Haghighi

Guilan University of Medical Sciences

manesthesist@gmail.com+1 313210434

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026